Consultant
Anne Voss
Department of Rheumatology, Odense University Hospital
Projekt styring | ||
Projekt status | Active | |
Data indsamlingsdatoer | ||
Start | 01.01.2015 | |
Slut | 31.12.2020 | |
Systemic lupus erythematosus (SLE) is a prototypic, autoimmune and potentially fatal connective tissue disease. In spite of its rarity (yearly incidence in Denmark 1-2/100.000) SLE has been intensively studied throughout the world clarifying a pathogenesis of multiple, complement activating autoantibodies causing inflammation and consequently tissue and organ damage.
We investigate the epidemiology of SLE prospectively since 1995 expanding the cohort to 208 patients as of 2013, with 1-6 consecutive blood samples from each patient coupled with a database covering disease manifestations, disease activity-scores, medical treatment etc.
Cardiovascular diseases (CVD) is an important negative predictive factor of survival in SLE and we presently investigate risk-factors including signs of atherosclerosis including coronary artery calcification measured by heart CT scans and carotid intima media thickening/plaques measured by means of B-mode ultrasound scans.
The aim is to identify and maintain a population-based cohort of SLE patients covering the Region of Southern Denmark. A database and a biobank are cultivated in order to describe potential biochemical markers of activity and damage in SLE
A population-based cohort of well characterized patients with SLE recruited from the Rheumatologic Departments in the Region of Southern Denmark.
We consecutively include incident and immigrated SLE patients aged 18+. Patients are invited to specific research-visits every 5 year including review of medical history, a clinical examination and blood-sampling. Extra examination and blood-sampling is performed if disease activity is suspected in-between research-visits.
Clinical data concerning diagnosis, activity score, damage score and risk factors for cardiovascular diseases.
Heart CT scans and carotid intima media thickening/plaques measured by means of B-mode ultrasound scans.
Serum (1-6 consecutive samples), plasma (1-4 consecutive samples) and DNA.
Department of Rheumatology, Odense University Hospital